The snapshot of the a mini outline of the content and quick facts

Generic name: modafinil. A well known brand: Provigil.

What it does: modafinil is prescribed to help adults stay awake when excessive daytime sleepiness is due to narcolepsy, obstructive sleep apnea (as an adjunct when primary therapy does not fully control sleepiness), or shift work sleep disorder.

Common tablet strengths sold in the United States are 100 mg and 200 mg.

For rapid access to practical steps use these links: dosing details at Proper usage and recommended dosage instructions, safety checks at Preventive safeguards and pre-use checklist, and cost comparisons at Typical retail overall costs in the United States.

Return to the earlier section the capstone

Mechanism and pharmacology

Modafinil is classified as a wakefulness-promoting agent rather than a traditional amphetamine stimulant. Its precise molecular mechanism is not fully defined.

Research indicates modafinil influences several brain systems involved in alertness: it can partially block the dopamine transporter, modulate orexin (hypocretin) pathways, enhance histaminergic tone, and indirectly affect norepinephrine circuits. These combined effects typically increase sustained attention and reduce sleepiness with a lower tendency to produce euphoria than many conventional stimulants.

Onset: many people notice increased alertness within a few hours of taking an oral dose. For shift work use, timing matters to gain benefit without disrupting nighttime sleep; see Instructions on dosing and usage for best timing tips.

Jump back to the number one spot

Use and dose instructions

• Initial adult dose commonly prescribed: 200 mg once daily. Some individuals achieve adequate benefit on 100 mg; clinicians will individualize dose according to response and tolerability.
• For narcolepsy and as adjunct therapy for obstructive sleep apnea, dosing is often 200 mg taken in the morning.
• For shift work sleep disorder, many patients take a single 200 mg dose approximately one hour before starting the scheduled work shift to enhance wakefulness during the shift.
• Food does not have to be taken with modafinil; a heavy, high-fat meal may delay absorption and postpone the onset of effect.
• Reduced doses are advisable for patients with severe liver impairment; older adults may need dose adjustment as well. Follow individualized medical advice.
• Do not change, stop, or increase your dose without discussing it with your health care provider. Treatment is usually reassessed after several weeks to months and continued only if benefits outweigh risks.

Always follow the directions on your prescription label merged with the guidance given by your healthcare team.

Snapshot in time of the an overarching view of the material and quick facts | Safety care steps and pre-use checklist | Up to the leading position

Precautionary steps and pre-use checklist

Do not take modafinil if you have had a serious allergic reaction or severe skin reaction to modafinil or armodafinil. If you develop rash, blistering, peeling skin, mouth sores, fever, swelling, or breathing difficulty, stop the medicine and seek urgent medical care.

Tell your prescriber about any history of the following so risks can be evaluated and monitored:

• Heart disease, including chest pain, prior myocardial infarction, abnormal heart rhythm, or structural cardiac conditions
• High blood pressure
• Hepatic or renal disorders
• Mood disorders, psychosis, severe anxiety, or a history of substance misuse

Fertility and birth control: the safety of modafinil in pregnancy is not fully established. Modafinil can reduce the effectiveness of many hormonal contraceptives (pills, patches, rings, implants, and some intrauterine devices). Use reliable non-hormonal contraception or add a barrier method during treatment and for at least one month after stopping. Discuss family planning in consultation with your clinician.

Drug communication in action considerations: modafinil may induce CYP3A4 and inhibit CYP2C19, altering blood levels of other medications. Notable dialogues include some hormonal contraceptives, selected antiepileptic drugs, certain antifungals, certain antidepressants, and warfarin. Provide a complete medication and supplement list to your pharmacist or prescriber.

Some people experience cognitive changes, slowed reactions, or altered judgment when starting or changing the dose. See Restricted activities and restricted substances to avoid for advice about driving and operating machinery.

Go back toward the page top

If a dose is missed

If you miss a scheduled dose consult your pharmacist or prescriber for instructions tailored to your situation. As a general rule, do not take a the medication dose was missed close to bedtime or at a time that would prevent restful sleep. Do not take two doses at once to replace a the medication dose was missed.

For shift workers: if a pre-shift dose is missed and you need recovery sleep, skip the dose and discuss a plan with your healthcare provider for future shifts.

Guidance on use and dosing | Jump to section on top of the page

Overdosing episode and Poison Control (USA)

If you suspect an consuming an overdose of modafinil seek emergency medical care immediately. For phone guidance in the United States call Poison Control at 1-800-222-1222 or visit poisonHelp dot org.

Possible overdosed on pills symptoms: severe agitation, rapid heart rate, nausea, vomiting, high blood pressure, and in serious situations seizures or loss of consciousness. Emergency treatment is supportive and focuses on cardiovascular and neurological tracking and monitoring of performance.

Go go to the beginning

Activities and substances not to engage in while taking modafinil

• Do not drive or operate heavy machinery until you know how modafinil affects you; some patients experience dizziness or slowed responses.
• Avoid or limit alcohol while taking modafinil; combining the two can unpredictably impair cognition or increase sleepiness for some people.
• Exercise caution when combining modafinil with other sedating medicines or potent stimulants; discuss additive effects with the guidance of your prescriber.

If your work involves safety-sensitive tasks consult employer policies and occupational health, since certain industries have specific rules about wakefulness-promoting agents.

Preventive care measures and pre-use checklist | Go move to the leading position

Possible safety notices and undesirable effects

Call for immediate medical help for a suspected emergency. severe allergic signs such as hives, facial or throat swelling, or difficulty breathing.

Stop the medication and get urgent care if any of the following serious events occur:

• Severe skin reactions including blistering or peeling rash, especially with fever
• New or worsening cardiac symptoms such as chest pain, shortness of breath, or irregular heartbeat
• Jaundice (yellowing of skin or eyes), dark urine, or marked leg swelling
• New psychiatric symptoms such as severe agitation, hallucinations, hostile behavior, or suicidal thoughts

More common and usually less major drug unintended consequences include:

• Head pain or lightheadedness
• Trouble getting to sleep or difficulty falling asleep
• Gastrointestinal symptoms such as nausea or diarrhea
• Spinal pain, nasal congestion, or nervousness

This list fails to cover all items. Contact your healthcare provider for any persistent, worsening, or concerning symptoms.

Go to top

Other options and related drugs

If modafinil is not appropriate, other options may be considered based on the underlying condition and individual safety needs.

• Armodafinil (brand Nuvigil or generic armodafinil) is the R-enantiomer of modafinil and can produce a similar effect with modest differences in duration for some patients.
• Solriamfetol (Sunosi) inhibits dopamine and norepinephrine transporters and is approved for excessive daytime sleepiness related to narcolepsy and OSA.
• Pitolisant (Wakix) works as an H3 histamine receptor inverse agonist and can be a non-stimulant a second possibility for some patients.
• Traditional stimulants such as methylphenidate (for example Ritalin, Concerta) and amphetamine formulations (for example Adderall, dextroamphetamine, lisdexamfetamine) are effective in many cases but have different side effect profiles and tighter regulatory controls.
• Nonpharmacologic strategies: treating sleep-disordered breathing effectively (for example with consistent CPAP), improving sleep hygiene, timing light exposure, and structured sleep schedules can reduce daytime sleepiness and sometimes lessen or remove the need for medication.

Discuss risks, benefits, and costs in collaboration with your prescriber. See cost notes at Typical retail uS cost figures.

Take me to the apex of something

Typical retail price levels for goods in the United States

Out-of-pocket prices vary by pharmacy, state, insurance coverage, and quantity dispensed. The following are approximate cash price gradient in US dollars to give a rough idea.

• Generic modafinil 200 mg: roughly $0.60 to $3.00 per tablet. A 30-tablet supply may cost about $20 to $90 at common cash prices.
• Provigil brand 200 mg: frequently much more expensive, often around $15 to $40 per tablet; 30 tablets can cost roughly $450 to $1,200 without discounts.
• Generic armodafinil (typical 150 mg or 250 mg strengths): often in the $0.70 to $3.00 per tablet range; branded Nuvigil is typically pricier.
• Solriamfetol (Sunosi): cash prices are commonly several hundred dollars per month, often in the $700 to $900 range without insurance.
• Pitolisant (Wakix): retail out-of-pocket costs may exceed $800 to $1,500 per month without coverage.

Insurance may require prior authorization or step therapy and formulary choices affect out-of-pocket costs. To lower expenses consider pharmacy discount cards, manufacturer savings programs, or choosing a generic product. Ask your pharmacist about available assistance and price-check multiple medicine shops.

Medicines related to different choices | Return to the context the peak of the page

United States regulatory and legal considerations guidance and notes

• Control status: modafinil is a Schedule IV controlled substance in the United States. A valid prescription from a licensed clinician is required for lawful possession and dispensing.
• Refills and prescribing: federal and state regulations affect refill limits and prescription validity; ongoing therapy often requires periodic re-evaluation and documentation.
• Telemedicine: rules for prescribing controlled substances via telehealth vary by state and circumstance. Some jurisdictions require an initial in-person evaluation or impose additional documentation standards.
• Importation restrictions: importing prescription medications into the United States is generally limited. Packages may be intercepted by customs or the FDA unless specific narrow exceptions apply.
• Workplace and safety-sensitive roles: employers and regulatory bodies (for example in aviation, transportation, or public safety) may set policies requiring disclosure, testing, or restrictions on use of wakefulness-promoting drugs.
• Sports and doping: modafinil and similar stimulants are commonly prohibited in-competition under many anti-doping rules unless a valid therapeutic use exemption is granted.
• The youth population and adolescents: safety and efficacy are less well established in pediatric populations; specialist consultation is recommended for younger patients.

State laws and employer policies may add requirements beyond federal rules. For case-specific legal or regulatory questions consult an attorney or your state licensing board. For medical guidelines for safety see Protective measures and pre-use checklist and Possible watch for undesirable health effects and warning bulletins.

Go to the capstone of the page